Amyloid-β contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy.
about
Cerebral Small Vessel Disease: Targeting Oxidative Stress as a Novel Therapeutic Strategy?Cerebrovascular disease in ageing and Alzheimer's diseaseRole of pro-inflammatory cytokines released from microglia in Alzheimer's diseaseThe pharmacological impact of ATP-binding cassette drug transporters on vemurafenib-based therapyImpact of age on the cerebrovascular proteomes of wild-type and Tg-SwDI miceTargeting transporters: promoting blood-brain barrier repair in response to oxidative stress injuryPathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesisIschemic brain injury in cerebral amyloid angiopathyEffect of TTP488 in patients with mild to moderate Alzheimer's disease.The role of Wnt signaling in the development of Alzheimer's disease: a potential therapeutic target?Occludin deficiency with BACE1 elevation in cerebral amyloid angiopathy.Vascular disruption and blood-brain barrier dysfunction in intracerebral hemorrhage.Mixed oligomers and monomeric amyloid-β disrupts endothelial cells integrity and reduces monomeric amyloid-β transport across hCMEC/D3 cell line as an in vitro blood-brain barrier model.Cerebral amyloid angiopathy impact on endothelium.Blood-brain barrier dysfunction and cerebral small vessel disease (arteriolosclerosis) in brains of older people.Matrix metalloproteinase-9 leads to claudin-5 degradation via the NF-κB pathway in BALB/c mice with eosinophilic meningoencephalitis caused by Angiostrongylus cantonensis.Advances in our Understanding of the Pathophysiology, Detection and Management of Cerebral Amyloid Angiopathy.Hemorrhagic Transformation after Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke: Mechanisms, Models, and Biomarkers.Visualization of microbleeds with optical histology in mouse model of cerebral amyloid angiopathy.Blood-Brain Barrier Permeability in Aging and Alzheimer's Disease.Translating basic science research to clinical application: models and strategies for intracerebral hemorrhage.High-Throughput Screening for Identification of Blood-Brain Barrier Integrity Enhancers: A Drug Repurposing Opportunity to Rectify Vascular Amyloid Toxicity.CD36 as a therapeutic target for endothelial dysfunction in stroke.Matrix metalloproteinase 9-mediated intracerebral hemorrhage induced by cerebral amyloid angiopathy.Autoregulated paracellular clearance of amyloid-β across the blood-brain barrierRestraint Stress-Induced Morphological Changes at the Blood-Brain Barrier in Adult Rats.Triggers and effectors of oxidative stress at blood-brain barrier level: relevance for brain ageing and neurodegenerationTight junction modulation of the blood brain barrier: CNS delivery of small moleculesHMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer's disease.Caloric restriction preserves memory and reduces anxiety of aging mice with early enhancement of neurovascular functions.The pathophysiology and clinical presentation of cerebral amyloid angiopathy.Successes and failures for drugs in late-stage development for Alzheimer's diseaseConvexity Subarachnoid Hemorrhage with PiB Positive Pet Scans: Clinical Features and Prognosis.Nanotherapeutic strategies for the treatment of Alzheimer's disease.18F-AV-1451 PET Imaging in Three Patients with Probable Cerebral Amyloid Angiopathy.The influence of the amyloid ß-protein and its precursor in modulating cerebral hemostasis.Matrix Metalloproteinase in Blood-Brain Barrier Breakdown in Dementia.Neurovascular Specifications in the Alzheimer-Like Brain of Mice Affected by Focal Cerebral Ischemia: Implications for Future Therapies.Matrix metalloproteinases in the brain and blood-brain barrier: Versatile breakers and makers.Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.
P2860
Q26751153-07C725B4-5AC4-48EB-9CA6-D987F08F8A60Q26771852-CC1D6E6A-A353-437B-A1AA-FC268E829DF0Q26799870-FFBAAD18-D668-43EA-B328-004AAE2E822AQ27004672-6596E2CA-1ED2-46B5-9EFD-71F072A2B180Q27319555-6794EEFA-2B15-433C-B3DF-5CF66B251640Q28088708-CF3485CE-E6F5-47CC-9AE4-0057E453642DQ30235369-8CA35574-8DB1-47C1-8F85-E48685FA19EAQ30945201-E1911AB6-588E-4820-AA8D-0B59310886F0Q33611402-9D233103-70F8-410B-84D1-C44869EF9B3FQ33634629-EEA24722-1DD3-43B3-A368-340E48FBEE1EQ33654643-4DA3A94E-669B-464B-AEEF-A49495E3A9F7Q34033129-866DEB71-B4AB-4FB9-88DD-44D095D12B8BQ34046424-498C5F85-99CB-4C03-93D0-F3C8D73B972AQ34297316-2B1AC195-C572-4059-A4CF-D586CC256048Q34406773-291A4D40-CDC7-4748-92C8-741B3575C8EFQ34625448-4C2CAB1C-943D-40E4-8477-3DA1E2638C80Q34994148-D221AE2A-709D-4BF4-94B2-D2CE02905224Q35567319-2E1E45D6-10FE-44BA-AA3D-6252298F01FFQ35923540-EBE26121-AF96-4420-90CD-A7E083E00B6DQ35976906-E9393E8E-1655-4A6B-99A7-28764321E973Q35993214-4AA0768E-EB2A-43F1-877C-5DA9FC6D47CCQ36071927-700C8A5F-C559-4A49-9A37-077881D1A7F1Q36139754-47516709-DA2D-4EB9-9809-EF32A62E8594Q36173578-626AAE46-DDDA-4D7A-AEE3-BAF405A6B7E6Q36174787-7E4FC880-19C3-4508-A1A7-5C23C28B58EAQ36460596-2C8ACB8E-E9F8-4521-AB92-298657A41306Q36711812-4EAE72D1-4AC9-4577-B91F-39676B367471Q36812411-D12818D0-968A-4892-9C99-0661630F6644Q37199557-8F56FEDB-DAB5-4A8C-AF1F-5E6097A2E69AQ37538210-B575B132-556D-41AA-8CEF-6311EC26C76DQ38008170-BD88D60F-71A1-4F05-8816-CF23A0C34196Q38128773-4D440D38-3219-40CC-BCB9-391A6983E2DDQ38293661-C42C5357-C173-4D55-9BBD-29B8817585BFQ38358865-02CD2626-8620-4E74-828E-13DE6F90119DQ38404963-506A201E-7825-4809-8A7B-53FD2DF67EBAQ38620895-39B73710-7D9B-4698-A102-A90C1504A783Q38645205-519FFA42-031A-4031-A767-C205BA698AF8Q38663632-2530DF6C-AC5F-4ADE-A046-3AB987BA66A6Q38870841-1C030362-806C-474F-872C-8C97CB9A7959Q38879090-2151B6EE-39CB-4C5C-8E23-DF534C00BC3D
P2860
Amyloid-β contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Amyloid-β contributes to blood ...... h cerebral amyloid angiopathy.
@en
Amyloid-β contributes to blood ...... h cerebral amyloid angiopathy.
@nl
type
label
Amyloid-β contributes to blood ...... h cerebral amyloid angiopathy.
@en
Amyloid-β contributes to blood ...... h cerebral amyloid angiopathy.
@nl
prefLabel
Amyloid-β contributes to blood ...... h cerebral amyloid angiopathy.
@en
Amyloid-β contributes to blood ...... h cerebral amyloid angiopathy.
@nl
P2093
P2860
P50
P1433
P1476
Amyloid-β contributes to blood ...... h cerebral amyloid angiopathy.
@en
P2093
Andrea Wolf
Anika M S Hartz
Björn Bauer
Emma L B Soldner
Hans H Klünemann
Ivan Mihaljevic
Roland Backhaus
Sandra Boy
P2860
P304
P356
10.1161/STROKEAHA.111.627562
P407
P577
2011-11-23T00:00:00Z